Tag: #asundexian

Articles related to asundexian

health

FDA Approves Sunharbo, First Factor XIa Inhibitor, to Reduce Recurrent Ischemic Stroke in High‑Risk Adults

FDA approved Sunharbo (asundexian), the first U.S. factor XIa inhibitor, to prevent recurrent ischemic stroke in certain high‑risk adults alongside antiplatelet therapy.

#stroke, #asundexian, #fda, #bayer, #fxia